6 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Zoonotic Anticipation and Preparedness Initiative (ZAPI)
Date du début: 1 mars 2015, Date de fin: 29 févr. 2020,
Emerging infectious diseases are occurring at increasing frequency in Europe and other regions of the world, having profound impacts on public and/or veterinary health as well as disruptive effects on sector, regional or even global economy. The predominantly zoonotic nature of emerging pathogens calls for a One Health approach uniting the human medical and veterinary fields, dedicated to swiftly ...
Voir le projet
21
Participants partenaires
TERMINÉ
Molecular Imaging of Brain Pathophysiology (BrainPath)
Date du début: 1 oct. 2013, Date de fin: 30 sept. 2017,
BRAINPATH aims to build upon current developments in molecular imaging by creating an academic-industrial training and mobility network for the next revolution of imaging technology. Molecular in vivo imaging is a fertile area which combines expertise, state-of-art equipment and many disciplines and inter-sector work environments. Our goal is to better understand brain diseases and develop new pre ...
Voir le projet
9
Participants partenaires
TERMINÉ
Hybrid imaging agents for the illumination of peripheral nerve structures (ILLUMINATING NERVES)
Date du début: 1 août 2012, Date de fin: 31 juil. 2017,
"The aim of the ILLUMINATING NERVES project is to develop and synthesize new imaging agents that eventually can be used for surgical guidance around delicate nerve structures. The applicants research group already has made a major contribution to the clinical field of surgical guidance by introducing a concept wherein a multimodal/hybrid, imaging agent is used to provide fully integrated preoperat ...
Voir le projet
1
Participant partenaire
TERMINÉ
A new therapeutic antibody with a personalised medicine approach in cardiovascular disease (CARDIMMUN)
Date du début: 1 août 2013, Date de fin: 31 juil. 2016,
"The project, CARDIMMUN, aims to pursue development of the scientific findings from the FP6 project CVDImmune. Based on our patented discovery, that low levels of anti-PC (phosphorylcholine) indicate risk for future development of cardiovascular disease, we have developed both a diagnostic test (a marker to identify cardiovascular disease patients that are at high risk of secondary events) and a c ...
Voir le projet
5
Participants partenaires
TERMINÉ
SUB nanosecond Leverage In PET/MR ImAging (SUBLIMA)
Date du début: 1 sept. 2010, Date de fin: 28 févr. 2015,
The SUBLIMA project aims at truly simultaneous, fully integrated, solid-state PET/MR technology for concurrent functional and anatomical imaging with unsurpassed image quality. It will combine the extremely sensitive functional imaging possibilities provided by PET with the excellent soft-tissue contrast and complementary functional imaging capabilities of MR. For the first time, time-of-flight (T ...
Voir le projet
14
Participants partenaires
TERMINÉ
Gaining sage on the Epoetins' saga: assessing long term risks and advancing towards better Epoetin driven treatment modalities (EPOCAN)
Date du début: 1 oct. 2011, Date de fin: 30 sept. 2014,
EpoCan aims to develop and implement a comprehensive interdisciplinary strategy to assess the long-term risks of erythropoietin (EPO) and its derivatives (epoetins) on tumour growth progression and thromboembolic events in cancer patients, cardiovascular events, and the development of cancer in chronic kidney disease. Approximately 400,000 patients across Europe receive epoetins treatment each yea ...
Voir le projet